Results

Total Results: 9,447 records

Showing results for "cancer".
Users also searched for: colon cancer screening

441. Nis 2001 Summarystats (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats.PDF
     January 01, 2001 - cancer of skin 1256 0.02 24: Cancer of breast 23750 0.32 25: Cancer of uterus 7363 0.10 26: Cancer … 29: Cancer of prostate 19815 0.27 30: Cancer of testis 388 0.01 31: Cancer of other male genital … , other Unspecified primary 1721 0.02 42: Secondary malignancies 50541 0.68 43: Malignant neoplasm … 0.13 45: Maintenance chemotherapy, radiotherapy 31799 0.43 46: Benign neoplasm of uterus 51230 0.69 … 47: Other unspecified benign neoplasm 35658 0.48 48: Thyroid disorders 7575 0.10 49: Diabetes mellitus

442. Nis 2001 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2001 - cancer of skin 113 0.02 24: Cancer of breast 2360 0.32 25: Cancer of uterus 753 0.10 26: Cancer of … : Cancer of prostate 2016 0.27 30: Cancer of testis 33 0.00 31: Cancer of other male genital organs … , other Unspecified primary 166 0.02 42: Secondary malignancies 5068 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3213 0.43 46: Benign neoplasm of uterus 5134 0.69 47: Other … unspecified benign neoplasm 3526 0.47 48: Thyroid disorders 738 0.10 49: Diabetes mellitus without

443. Nis 2000 Summarystats (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats.PDF
     January 01, 2000 - cancer of skin 1350 0.02 24: Cancer of breast 24977 0.34 25: Cancer of uterus 7538 0.10 26: Cancer … 29: Cancer of prostate 19223 0.26 30: Cancer of testis 389 0.01 31: Cancer of other male genital … , other Unspecified primary 1711 0.02 42: Secondary malignancies 49806 0.67 43: Malignant neoplasm … 0.12 45: Maintenance chemotherapy, radiotherapy 32967 0.44 46: Benign neoplasm of uterus 52589 0.71 … 47: Other unspecified benign neoplasm 33742 0.45 48: Thyroid disorders 7619 0.10 49: Diabetes mellitus

444. Nis 2000 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2000 - cancer of skin 156 0.02 24: Cancer of breast 2610 0.35 25: Cancer of uterus 752 0.10 26: Cancer of … : Cancer of prostate 1911 0.26 30: Cancer of testis 36 0.00 31: Cancer of other male genital organs … , other Unspecified primary 162 0.02 42: Secondary malignancies 4927 0.66 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3283 0.44 46: Benign neoplasm of uterus 5279 0.71 47: Other … unspecified benign neoplasm 3318 0.45 48: Thyroid disorders 734 0.10 49: Diabetes mellitus without

445. Nis 2000 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2000 - cancer of skin 135 0.02 24: Cancer of breast 2524 0.34 25: Cancer of uterus 741 0.10 26: Cancer of … : Cancer of prostate 2014 0.27 30: Cancer of testis 45 0.01 31: Cancer of other male genital organs … , other Unspecified primary 175 0.02 42: Secondary malignancies 5041 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3285 0.44 46: Benign neoplasm of uterus 5331 0.72 47: Other … unspecified benign neoplasm 3370 0.45 48: Thyroid disorders 734 0.10 49: Diabetes mellitus without

446. Nis 2002 Summarystats 10Pct Sample A (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_A.PDF
     January 01, 2002 - cancer of skin 139 0.02 24: Cancer of breast 2343 0.30 25: Cancer of uterus 821 0.10 26: Cancer of … : Cancer of prostate 2013 0.26 30: Cancer of testis 33 0.00 31: Cancer of other male genital organs … , other Unspecified primary 204 0.03 42: Secondary malignancies 5351 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3557 0.45 46: Benign neoplasm of uterus 5501 0.70 47: Other … unspecified benign neoplasm 3605 0.46 48: Thyroid disorders 829 0.11 49: Diabetes mellitus without

447. Nis 2002 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2002 - cancer of skin 126 0.02 24: Cancer of breast 2252 0.29 25: Cancer of uterus 862 0.11 26: Cancer of … : Cancer of prostate 2080 0.26 30: Cancer of testis 38 0.00 31: Cancer of other male genital organs … , other Unspecified primary 220 0.03 42: Secondary malignancies 5231 0.67 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3506 0.45 46: Benign neoplasm of uterus 5578 0.71 47: Other … unspecified benign neoplasm 3552 0.45 48: Thyroid disorders 846 0.11 49: Diabetes mellitus without

448. Nis 2001 Summarystats 10Pct Sample B (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_B.PDF
     January 01, 2001 - cancer of skin 163 0.02 24: Cancer of breast 2392 0.32 25: Cancer of uterus 729 0.10 26: Cancer of … : Cancer of prostate 1997 0.27 30: Cancer of testis 36 0.00 31: Cancer of other male genital organs … , other Unspecified primary 153 0.02 42: Secondary malignancies 5035 0.68 43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3134 0.42 46: Benign neoplasm of uterus 5150 0.69 47: Other … unspecified benign neoplasm 3541 0.48 48: Thyroid disorders 753 0.10 49: Diabetes mellitus without

449. Prostate Cancer Screening Recommendation Frequently Asked Questions (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFileByToken/-BbKrbuLt9RAPvf3BQrUMW
     The PSA test and follow-up prostate biopsies can’t tell for sure which cancers will likely be aggressive … and spread and which will not—or which cancers will grow so slowly that they will never cause symptoms … Until we have better screening tests to distinguish men who will have cancers that spread from those … Treating these cancers early may not alter their course, and the cancer may not cause any problems … There are also aggressive cancers that do not respond well to current treatments.

450. Colorectal Cancer | Digital Healthcare Research
     digital.ahrq.gov/medical-condition/colorectal-cancer
     January 01, 2024 - Colorectal Cancer Oncology patients' willingness to report their medication … Connected Cancer Care: EHR Communication Networks in Virtual Cancer Care Teams - Final Report. … increased cancer knowledge in a randomized controlled trial. … Cancer Control. 2021 Jan-Dec;28:10732748211036783. doi: 10.1177/10732748211036783. … Connected Cancer Care: Electronic Health Record Communication Networks in Virtual Cancer Care

451. Lung Cancer | Digital Healthcare Research
     digital.ahrq.gov/medical-condition/lung-cancer
     January 01, 2024 - Lung Cancer Patient perspectives on a patient-facing tool for lung cancer … Patient perspectives on a patient-facing tool for lung cancer screening. … Decision Support at Scale Implementation of lung cancer screening in primary … Methods for using race and ethnicity in prediction models for lung cancer screening eligibility. … Connected Cancer Care: EHR Communication Networks in Virtual Cancer Care Teams - Final Report.

452. Prostate Cancer | Digital Healthcare Research
     digital.ahrq.gov/medical-condition/prostate-cancer
     January 01, 2024 - Prostate Cancer Oncology patients' willingness to report their medication … Support Care Cancer. 2024 May 15;32(6):352. doi: 10.1007/s00520-024-08565-5. PMID: 38748294. … Project Name eHealth Activity Among African-American and White Cancer Survivors … eCoach: Development and Pilot Testing of a Decision Aid for Prostate Cancer - Final Report … Using Electronic Data to Improve Care of Patients With Known or Suspected Cancer - Final Report.

453. EPC Systematic Review Protocol: Achieving Health Equity in Preventive Services: Systematic Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
     January 01, 2020 - incidence, advanced breast cancer, breast cancer mortality, and all-cause mortality, quality-of-life … Breast cancer screening 4. Cervical cancer screening 5. Colorectal cancer screening 6. … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity

454. Cer-265-Radiation-Bone-Disease-Addendum-App (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-addendum-app.xlsx
     May 29, 2025 - Prior and Concurrent Treatments Site of Bone Metastases Characteristics of Bone Metastases Primary Tumor … asymptomatic metastases allowed; NRS pain ≥5; Epidural lesions with at least a 3-mm gap between the tumor … cord, and paraspinal masses (<5 cm) directly attached to the vertebral body permitted; Radioresistant cancers … permitted; Systemic/visceral metastases/uncontrolled primary tumors with >6 months median survival time … Quality of life: Functional Assessment of Cancer Therapy - General (FACT-G) Brief Pain Inventory (BPI

455. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvDjnZzW9PDxzKBauB4QxA
     August 21, 2018 - MAIN OUTCOMES AND MEASURES Invasive cervical cancer; cervical intraepithelial neoplasia (CIN); false-positive … testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised … Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial … Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I—all cancers and lung … cancer and part II—colorectal, prostate, breast, and cervical cancers.

456. Cervical Cancer | Digital Healthcare Research
     digital.ahrq.gov/medical-condition/cervical-cancer
     January 01, 2023 - Cervical Cancer Improving the accuracy of a clinical decision support … system for cervical cancer screening and surveillance. … Improving the accuracy of a clinical decision support system for cervical cancer screening and surveillance … NLP-enabled Decision Support for Cervical Cancer Screening and Surveillance - Final Report. … Non-visit-based cancer screening using a novel population management system.

457. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49761/psn-pdf
     May 01, 2016 - Although subsolid nodules are often malignant or premalignant, they usually give rise to malignancies … Although subsolid nodules are more often malignant or premalignant, they usually give rise to malignancies … that behave more indolently than solid malignancies. … lung cancer. … Clin Cancer Res. 2007;13:4949-4950. [go to PubMed] 7.

458. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49434/psn-pdf
     February 01, 2004 - Optimizing outcomes from cervical neoplasia involves multiple steps: the patient's ability and willingness … Cervical neoplasia is a slow growing disease, taking 10-30 years to progress from Human Papilloma Virus … (HPV) infection and low grade neoplasia to invasive cancer. … virus or more sensitive screening tests such as the Thin-Prep smear to detect clinically important neoplasia … Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou

459. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
     January 01, 2010 - using total PSA without PCA3 Outcome(s): Intermediate outcomes – diagnostic accuracy for detection of tumor … the PCA3 assay differentiate between clinically significant and clinically insignificant prostate cancers … a reduction in cancer-related morbidity or mortality? … Potential for clinically significant prostate cancers to be missed in individuals presumed to be at … )  The burden of prostate cancer is significant.

460. Nrd 2014 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
     January 01, 2014 - W MCC 19,595 0.13% 181: RESPIRATORY NEOPLASMS W CC 18,823 0.13% 182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 11,011 0.07% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … ; other and unspecified primary 3,146 0.02% 42: Secondary malignancies 90,574 0.61% 43: Malignant neoplasm … 19,338 0.13% 45: Maintenance chemotherapy; radiotherapy 64,899 0.44% 46: Benign neoplasm of uterus … 54,997 0.37% 47: Other and unspecified benign neoplasm 58,573 0.39% 48: Thyroid disorders 13,760 0.09%